EverydayHealthLogo
Dr. Nelson Teng, MD

Dr. Nelson Teng, MD

Stanford, CA

42 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Teng, Obstetrician / Gynecologist (OBGYN) in Stanford, CA?

    Dr. Nelson Teng, MD is an Obstetrician / Gynecologist (OBGYN), who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 42 years and is board certified by the American Board of Obstetrics and Gynecology. Dr. Teng completed his residency at Ucla Med Ctr, Obstetrics And Gynecology. Dr. Teng is fluent in English and Chinese, and is currently seeing new patients. Dr. Teng’s practice accepts Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Teng’s office at (650) 498-8080.

    What are Areas of Expertise for Dr. Teng?

    Dr. Nelson Teng, MD is a highly-rated, board-certified Obstetrician / Gynecologist (OBGYN) known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Teng empowers patients to confidently navigate their health journey, specializing in Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Uterine Cancer, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Teng is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Teng go to medical school and complete their residency?

    • Fellowship: Stanford University School of Medicine CA | Stanford University School of Medicine,Stanford, Ca, United States

    • Residency: Ucla Med Ctr, Obstetrics And Gynecology | UCLA Medical Center | University of California, Los Angeles

    • Medical School: University of Miami Sch of Med, Miami Fl

    Is Dr. Teng board certified in Obstetrician / Gynecologist (OBGYN)?

    Yes, Dr. Nelson Teng, MD is board certified by the American Board of Obstetrics and Gynecology , American Board of Obstetrics and Gynecology since 1987, American Board of Obstetrics and Gynecology since 1985

    What languages does Dr. Teng speak?

    Dr. Teng and their clinical team can communicate with patients in the following languages:

    • Chinese

    • English

    Which procedures does Dr. Teng perform as a Obstetrician / Gynecologist (OBGYN)?

    As a Obstetrician / Gynecologist (OBGYN), procedures performed by an Dr. Nelson Teng may include:

    For detailed information, please contact Dr. Teng's office.

    Does Dr. Teng accept my insurance?

    Dr. Teng accepts most major insurance plans. Important: Please call our office at (650) 498-8080 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Teng accept in Stanford, CA?

    Dr. Teng in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • Medicare

    • UnitedHealthcare

    View All Insurances

    Where is Dr. Teng's office located?

    Dr. Nelson Teng's Primary Practice

    300 Pasteur Dr

    Stanford, CA 94305

    (650) 498-8080

    Get Directions

    Dr. Nelson Teng's Practice 2

    900 Blake Wilbur Dr

    Palo Alto, CA 94304

    Get Directions

    Recognitions

    Publications

    The CD47-sigl regulatory protein alpha

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2012

    Wnt and Hedgehog Gene Pathway Expression in Serous Ovarian Cancer

    INTERTIOL JOURL OF GYNECOLOGICAL CANCER, 2011

    Gynecologic maligncies in female-to-male transgender patients

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 2011

    Squamous Cell Carcinoma Arising From Mature Cystic Teratoma of the Ovary

    INTERTIOL JOURL OF GYNECOLOGICAL CANCER, 2011

    INTRAOPERATIVE RADIATION THERAPY FOR LOCALLY ADVANCED AND RECURRENT SOFT-TISSUE SARCOMAS IN ADULTS

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Integrative proteomic

    JOURL OF PROTEOME RESEARCH, 2008

    Ovarian cancer. Clinical practice guidelines in oncology.

    Jourl of the tiol Comprehensive Cancer Network, 2008

    tural frequency alysis of tooth stability under various simulated types

    Proceedings of the Institution of Mechanical Engineers. Part H, Jourl , 2008

    Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 2008

    Trends in demographic and clinical characteristics in women diagnosed with corpus cancer

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 2008

    Ovarian clear cell carcinoma with papillary features

    AMERICAN JOURL OF SURGICAL PATHOLOGY, 2008

    A novel technique for the enrichment of primary ovarian cancer cells

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 2007

    Long-term survivors using intraoperative radiotherapy for recurrent gynecologic maligncies

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

    The potential therapeutic role of lymph node resection in epithelial ovarian cancer

    BRITISH JOURL OF CANCER, 2007

    Prognostic factors for outcomes

    GYNECOLOGIC ONCOLOGY, 2007

    Effects of human monoclol antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro

    PEDIATRIC BLOOD & CANCER, 2007

    Safety and efficacy of lelidomide (Revlimid((R)))

    GYNECOLOGIC ONCOLOGY, 2007

    Prognostic factors responsible for survival in sex cord stromal tumors of the ovary

    GYNECOLOGIC ONCOLOGY, 2007

    Ovarian cancer in younger vs older women: a population-based alysis

    BRITISH JOURL OF CANCER, 2006

    Ovarian cancer. Clinical practice guidelines in oncology.

    Jourl of the tiol Comprehensive Cancer Network, 2006

    Uterine cancers.

    Jourl of the tiol Comprehensive Cancer Network, 2006

    Uterine papillary serous

    BRITISH JOURL OF CANCER, 2006

    Improved survival of Asians with corpus cancer compared with whites

    OBSTETRICS AND GYNECOLOGY, 2006

    Intraoperative radiation therapy in recurrent ovarian cancer

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

    Impact of adjuvant therapy on survival of patients with early

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

    A modified technique for insertion of intraperitoneal port for chemotherapy

    JOURL OF SURGICAL ONCOLOGY, 2005

    Cervical cancer guidelines. Clinical practice guidelines in oncology.

    Jourl of the tiol Comprehensive Cancer Network, 2004

    Differential expression of CD40 and CD95 in ovarian carcinoma

    EUROPEAN JOURL OF GYECOLOGICAL ONCOLOGY, 2004

    Epoxidation of chiral camphor N-enoylpyrazolidinones with methyl

    JOURL OF ORGANIC CHEMISTRY, 2003

    Modification of the vertical rectus abdominis musculocutaneous

    ANLS OF PLASTIC SURGERY, 2003

    Preoperative CT diagnosis of primary fallopian tube carcinoma

    JOURL OF COMPUTER ASSISTED TOMOGRAPHY, 2003

    VH4-34 encoded antibody in systemic lupus erythematosus: Effect of Isotype

    JOURL OF RHEUMATOLOGY, 2002

    A new approach to enhancement of bone formation by electrically polarized hydroxyapatite

    JOURL OF DENTAL RESEARCH, 2001

    Effect of 17 beta-estradiol or alendrote on the bone densitometry

    BRAZILIAN JOURL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001

    Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000

    Recognition of auto- and exoantigens by V4-34 gene encoded antibodies

    SCANDIVIAN JOURL OF IMMUNOLOGY, 2000

    Primary leiomyosarcoma of the vagi. A case report and literature review.

    Intertiol jourl of gynecological cancer : official jourl of the Intert, 2000

    Malignt granular cell tumor of the vulva in a 17-year-old: Case report and literature review.

    Intertiol jourl of gynecological cancer : official jourl of the Intert, 2000

    VH4-34 encoded antibodies in systemic lupus erythematosus

    JOURL OF RHEUMATOLOGY, 1999

    Clinical practice guidelines in the magement of gynecologic maligncies

    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999

    Cytotoxicity of murine B lymphocytes induced by human VH4-34

    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997

    Rapid cytotoxicity of human B lymphocytes induced by VH4-34

    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997

    V(H)4-34(V(H)4.21) gene expression in the chronic arthritides of childhood

    JOURL OF RHEUMATOLOGY, 1996

    NCCN Ovarian Cancer Practice Guidelines. The tiol Comprehensive Cancer Network.

    Oncology (Williston Park, N.Y.), 1996

    Rapid cytotoxicity of human B lymphocytes induced by VH4-34

    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996

    Phase 1 trial of intraperitoneal AD-32 in gynecologic maligncies

    GYNECOLOGIC ONCOLOGY, 1996

    Operative laparoscopy in the magement of ovarian cancer

    SURGICAL LAPAROSCOPY & ENDOSCOPY, 1996

    ANTIENDOTOXIN HUMAN MONOCLOL-ANTIBODY A6H4C5 (HA-1A) UTILIZES THE VH4.21 GENE

    Bieber, M. M., Bhat, N. M., Teng, N. N., 1995

    HUMAN CD5+ B-LYMPHOCYTES (B-1 CELLS) DECREASE IN PERIPHERAL-BLOOD DURING PREGNCY

    JOURL OF REPRODUCTIVE IMMUNOLOGY, 1995

    THE ROLE OF LAPAROSCOPY IN THE MAGEMENT OF GYNECOLOGIC MALIGNCY

    SEMIRS IN SURGICAL ONCOLOGY, 1994

    FACS ALYSIS OF PERITONEAL LYMPHOCYTES IN OVARIAN-CANCER AND CONTROL PATIENTS

    IMMUNOBIOLOGY, 1994

    HUMAN ANTILIPID A MONOCLOL-ANTIBODIES BIND TO HUMAN B-CELLS AND THE I-ANTIGEN ON CORD

    JOURL OF IMMUNOLOGY, 1993

    PERITONEAL IMPLANT ELIMITION DURING CYTOREDUCTIVE SURGERY FOR OVARIAN-CANCER - IMPACT ON SURVIVAL

    GYNECOLOGIC ONCOLOGY, 1993

    DOCUMENTATION OF COMPLETE RESOLUTION OF GESTATIOL CHORIOCARCINOMA IN THE OOPHORECTOMIZED PATIENT

    GYNECOLOGIC ONCOLOGY, 1993

    LIPOPOLYSACCHARIDE AND PEPTIDOGLYCAN SHARE BINDING-SITES ON HUMAN PERIPHERAL-BLOOD MONOCYTES

    JOURL OF INFECTIOUS DISEASES, 1993

    ONE-STEP ENRICHMENT OF NUCLEATED RED-BLOOD-CELLS - A POTENTIAL APPLICATION IN PERITAL DIAGNOSIS

    JOURL OF IMMUNOLOGICAL METHODS, 1993

    Adenocarcinoma-reactive human monoclol antibody MS2B6 defines an antigen in simple gl

    Human antibodies and hybridomas, 1992

    HUMAN MONOCLOL-ANTIBODY RECOGNIZING AN ANTIGEN ASSOCIATED WITH OVARIAN AND OTHER ADENOCARCINOMAS

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 1992

    THE ONTOGENY AND FUNCTIOL-CHARACTERISTICS OF HUMAN B-1 (CD5+B) CELLS

    INTERTIOL IMMUNOLOGY, 1992

    TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK WITH HA

    NEW ENGLAND JOURL OF MEDICINE, 1991

    WOMEN WITH PREECLAMPSIA HAVE HIGHER PLASMA ENDOTHELIN LEVELS THAN WOMEN WITH NORMAL PREGNCIES

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990

    ONE-STEP SEPARATION OF HUMAN FETAL LYMPHOCYTES FROM NUCLEATED RED-BLOOD-CELLS

    JOURL OF IMMUNOLOGICAL METHODS, 1990

    INITIAL EVALUATION OF A HUMAN IMMUNOGLOBULIN-M MONOCLOL-ANTIBODY (HA-1A) IN HUMANS

    JOURL OF BIOLOGICAL RESPONSE MODIFIERS, 1990

    A RANDOMIZED COMPARATIVE TRIAL OF CARBOPLATIN AND IPROPLATIN IN ADVANCED SQUAMOUS CARCINOMA

    JOURL OF CLINICAL ONCOLOGY, 1989

    RADIATION-THERAPY FOR PRIMARY SQUAMOUS-CELL CARCINOMA OF THE VAGI - STANFORD-UNIVERSITY EXPERIENCE

    GYNECOLOGIC ONCOLOGY, 1989

    DELETION OF HISTO-BLOOD GROUP

    JOURL OF THE TIOL CANCER INSTITUTE, 1989

    EFFECTS OF ANTI-LIPID A HUMAN MONOCLOL

    JOURL OF UROLOGY, 1989

    TOPICAL INTERFERON FOR TREATING CONDYLOMA ACUMITA IN WOMEN

    JOURL OF INFECTIOUS DISEASES, 1988

    GENERATION OF HUMAN MONOCLOL-ANTIBODIES TO CANCER

    JOURL OF IMMUNOLOGICAL METHODS, 1987

    SINGLE-DOSE ACTINOMYCIN

    CANCER, 1987

    CLINICAL-APPLICATIONS OF MONOCLOL-ANTIBODIES IN GYNECOLOGIC ONCOLOGY

    CANCER, 1987

    THE EFFECT OF HUMAN ANTIENDOTOXIN MONOCLOL-ANTIBODIES ON ENDOTOXIN-INDUCED LUNG INJURY IN THE RAT

    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987

    EPITHELIAL OVARIAN-CARCINOMA IN PATIENTS WITH INTERSEX DISORDERS

    GYNECOLOGIC ONCOLOGY, 1986

    INFLUENCE OF AVIDITY AND IDIOTOPE RECOGNITION ON THE MODULATION OF SURFACE

    JOURL OF IMMUNOLOGY, 1986

    PROTECTION AGAINST GRAM-NEGATIVE BACTEREMIA AND ENDOTOXEMIA WITH HUMAN MONOCLOL IGM ANTIBODIES

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1985

    ANTIBODIES TO PEPTIDES CORRESPONDING TO A CONSERVED SEQUENCE OF GONOCOCCAL PILINS BLOCK BACTERIAL

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1985

    PRODUCTION OF HUMAN MONOCLOL IGG ANTIBODIES AGAINST RHESUS (D) ANTIGEN

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1984

    PARTIAL HYDATIDIFORM MOLE WITH DIPLOID KARYOTYPE - REPORT OF 3 CASES

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 1984

    SOMATIC-CELL HYBRID SELECTION WITH A TRANSFECTABLE DOMINT MARKER

    SOMATIC CELL AND MOLECULAR GENETICS, 1984

    MONOCLOL VERSUS POLYCLOL ANTIBODY-RADIOIMMUNOASSAY AGAINST THE BETA

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 1983

    CONSTRUCTION AND TESTING OF MOUSE HUMAN HETEROMYELOMAS FOR HUMAN MONOCLOL-ANTIBODY PRODUCTION

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1983

    CHARACTERIZATION OF AN ALPHA-BUNGAROTOXIN BINDING COMPONENT FROM DROSOPHILA - MELANOGASTER

    JOURL OF NEUROCHEMISTRY, 1977

    APPEARANCE OF ACETYLCHOLINE RECEPTORS IN CULTURED MYOBLASTS PRIOR TO FUSION

    JOURL OF SUPRAMOLECULAR STRUCTURE, 1976

    Taxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinoma

    GYNECOLOGIC ONCOLOGY, 2012

    The CD47-signal regulatory protein alpha

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2012

    Prox-1, Podoplanin and HPV staining assists in identification of lymphangioma circumscriptum of the

    HISTOPATHOLOGY, 2011

    Wnt and Hedgehog Gene Pathway Expression in Serous Ovarian Cancer

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011

    Gynecologic malignancies in female-to-male transgender patients

    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011

    The incidence of isolated para

    GYNECOLOGIC ONCOLOGY, 2011

    Squamous Cell Carcinoma Arising From Mature Cystic Teratoma of the Ovary

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011

    Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression

    Infectious diseases in obstetrics and gynecology, 2011

    INTRAOPERATIVE RADIATION THERAPY FOR LOCALLY ADVANCED AND RECURRENT SOFT-TISSUE SARCOMAS IN ADULTS

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Integrative proteomic

    JOURNAL OF PROTEOME RESEARCH, 2008

    Ovarian cancer. Clinical practice guidelines in oncology.

    Journal of the National Comprehensive Cancer Network, 2008

    Natural frequency analysis of tooth stability under various simulated types

    Proceedings of the Institution of Mechanical Engineers. Part H, Journa, 2008

    Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid

    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008

    Trends in demographic and clinical characteristics in women diagnosed with corpus cancer

    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008

    Ovarian clear cell carcinoma with papillary features

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008

    Cervical cancer screening.

    Partridge, E. E., Abu-Rustum, N., Campos, S., Fahey, P. J., Greer, B.

    Cervical cancer.

    Greer, B. E., Koh, W., Abu-Rustum, N., Bookman, M. A., Bristow, R. E.,

    A novel technique for the enrichment of primary ovarian cancer cells

    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007

    Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

    Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy

    GYNECOLOGIC ONCOLOGY, 2007

    The potential therapeutic role of lymph node resection in epithelial ovarian cancer

    BRITISH JOURNAL OF CANCER, 2007

    Lymphadenectomy in endometrioid uterine cancer staging

    CANCER, 2007

    Influence of the gynecologic oncologist on the survival of ovarian cancer patients

    OBSTETRICS AND GYNECOLOGY, 2007

    Prognostic factors for outcomes

    GYNECOLOGIC ONCOLOGY, 2007

    Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro

    PEDIATRIC BLOOD & CANCER, 2007

    Safety and efficacy of lenalidomide (Revlimid((R)))

    GYNECOLOGIC ONCOLOGY, 2007

    Prognostic factors for uterine cancer in reproductive-aged women

    OBSTETRICS AND GYNECOLOGY, 2007

    Prognostic factors responsible for survival in sex cord stromal tumors of the ovary

    GYNECOLOGIC ONCOLOGY, 2007

    Association of lymphadenectomy and survival in stage I ovarian cancer patients

    OBSTETRICS AND GYNECOLOGY, 2007

    Disruption of actin filaments by latrunculin B affects cell wall construction

    PLANT AND CELL PHYSIOLOGY, 2007

    Mesonephric adenocarcinoma of the cervix: A case report and review of the literature

    GYNECOLOGIC ONCOLOGY, 2006

    The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma

    GYNECOLOGIC ONCOLOGY, 2006

    Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma

    GYNECOLOGIC ONCOLOGY, 2006

    Ovarian cancer in younger vs older women: a population-based analysis

    BRITISH JOURNAL OF CANCER, 2006

    The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of

    GYNECOLOGIC ONCOLOGY, 2006

    Therapeutic role of lymph node resection in endometrioid corpus cancer - A study of 12,333 patients

    CANCER, 2006

    Ovarian cancer. Clinical practice guidelines in oncology.

    Journal of the National Comprehensive Cancer Network, 2006

    Outcomes of women with metachronous breast and ovarian carcinomas

    GYNECOLOGIC ONCOLOGY, 2006

    Breast cancer followed by corpus cancer: Is there a higher risk for aggressive histologic subtypes?

    GYNECOLOGIC ONCOLOGY, 2006

    Patterns and progress in ovarian cancer over 14 years

    OBSTETRICS AND GYNECOLOGY, 2006

    Uterine cancers.

    Journal of the National Comprehensive Cancer Network, 2006

    Enhanced killing of primary ovarian cancer by retargeting autologous cytokine

    CLINICAL CANCER RESEARCH, 2006

    Uterine papillary serous

    BRITISH JOURNAL OF CANCER, 2006

    Improved survival of Asians with corpus cancer compared with whites

    OBSTETRICS AND GYNECOLOGY, 2006

    Elevated CO2 induces physiological

    NEW PHYTOLOGIST, 2006

    Intraoperative radiation therapy in recurrent ovarian cancer

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

    Impact of adjuvant therapy on survival of patients with early

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

    A modified technique for insertion of intraperitoneal port for chemotherapy

    JOURNAL OF SURGICAL ONCOLOGY, 2005

    Cervical cancer guidelines. Clinical practice guidelines in oncology.

    Journal of the National Comprehensive Cancer Network, 2004

    Detection of pelvic lymph node micrometastasis in stage IA2

    GYNECOLOGIC ONCOLOGY, 2004

    Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma

    CANCER, 2004

    B cell lymphoproliferative disorders and VH4-34 gene encoded antibodies.

    Human antibodies, 2004

    Differential expression of CD40 and CD95 in ovarian carcinoma

    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004

    Epoxidation of chiral camphor N-enoylpyrazolidinones with methyl

    JOURNAL OF ORGANIC CHEMISTRY, 2003

    Modification of the vertical rectus abdominis musculocutaneous

    ANNALS OF PLASTIC SURGERY, 2003

    Gene expression patterns in ovarian carcinomas

    MOLECULAR BIOLOGY OF THE CELL, 2003

    Preoperative CT diagnosis of primary fallopian tube carcinoma

    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2003

    Liposomal doxorubicin for treatment of metastatic chemorefractory vulvar adenocarcinoma

    GYNECOLOGIC ONCOLOGY, 2002

    VH4-34 encoded antibody in systemic lupus erythematosus: Effect of Isotype

    JOURNAL OF RHEUMATOLOGY, 2002

    A new approach to enhancement of bone formation by electrically polarized hydroxyapatite

    JOURNAL OF DENTAL RESEARCH, 2001

    Effect of 17 beta-estradiol or alendronate on the bone densitometry

    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001

    Susceptibility of B-cell lymphoma to human antibodies encoded by the V4-34 gene

    Bhat, N. M., Bieber, M. M., Young, L. W., Teng, N. N., 2001

    Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000

    Recognition of auto- and exoantigens by V4-34 gene encoded antibodies

    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2000

    Primary leiomyosarcoma of the vagina. A case report and literature review.

    International journal of gynecological cancer : official journal of th, 2000

    Malignant granular cell tumor of the vulva in a 17-year-old: Case report and literature review.

    International journal of gynecological cancer : official journal of th, 2000

    VH4-34 encoded antibodies in systemic lupus erythematosus

    JOURNAL OF RHEUMATOLOGY, 1999

    Clinical practice guidelines in the management of gynecologic malignancies

    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999

    Cytotoxicity of murine B lymphocytes induced by human VH4-34

    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997

    Rapid cytotoxicity of human B lymphocytes induced by VH4-34

    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997

    Heavy chain variable gene usage by human B-1 lymphocytes and polyreactive autoantibodies.

    Human antibodies, 1997

    V(H)4-34(V(H)4.21) gene expression in the chronic arthritides of childhood

    JOURNAL OF RHEUMATOLOGY, 1996

    Lymphangioleiomyomatosis of the uterus simulating high-stage endometrial stromal sarcoma

    GYNECOLOGIC ONCOLOGY, 1996

    NCCN Ovarian Cancer Practice Guidelines. The National Comprehensive Cancer Network.

    Oncology (Williston Park, N.Y.), 1996

    Rapid cytotoxicity of human B lymphocytes induced by VH4-34

    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996

    Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies

    GYNECOLOGIC ONCOLOGY, 1996

    Operative laparoscopy in the management of ovarian cancer

    SURGICAL LAPAROSCOPY & ENDOSCOPY, 1996

    The female genital tract.

    Pathology (Philadelphia, Pa.), 1996

    ANTIENDOTOXIN HUMAN MONOCLONAL-ANTIBODY A6H4C5 (HA-1A) UTILIZES THE VH4.21 GENE

    Bieber, M. M., Bhat, N. M., Teng, N. N., 1995

    HUMAN CD5+ B-LYMPHOCYTES (B-1 CELLS) DECREASE IN PERIPHERAL-BLOOD DURING PREGNANCY

    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1995

    THE ROLE OF LAPAROSCOPY IN THE MANAGEMENT OF GYNECOLOGIC MALIGNANCY

    SEMINARS IN SURGICAL ONCOLOGY, 1994

    FACS ANALYSIS OF PERITONEAL LYMPHOCYTES IN OVARIAN-CANCER AND CONTROL PATIENTS

    IMMUNOBIOLOGY, 1994

    HUMAN ANTILIPID A MONOCLONAL-ANTIBODIES BIND TO HUMAN B-CELLS AND THE I-ANTIGEN ON CORD

    JOURNAL OF IMMUNOLOGY, 1993

    PERITONEAL IMPLANT ELIMINATION DURING CYTOREDUCTIVE SURGERY FOR OVARIAN-CANCER - IMPACT ON SURVIVAL

    GYNECOLOGIC ONCOLOGY, 1993

    DOCUMENTATION OF COMPLETE RESOLUTION OF GESTATIONAL CHORIOCARCINOMA IN THE OOPHORECTOMIZED PATIENT

    GYNECOLOGIC ONCOLOGY, 1993

    LIPOPOLYSACCHARIDE AND PEPTIDOGLYCAN SHARE BINDING-SITES ON HUMAN PERIPHERAL-BLOOD MONOCYTES

    JOURNAL OF INFECTIOUS DISEASES, 1993

    LONG-TERM SURVIVAL WITH ADJUVANT WHOLE ABDOMINOPELVIC IRRADIATION FOR UTERINE PAPILLARY SEROUS

    CANCER, 1993

    ONE-STEP ENRICHMENT OF NUCLEATED RED-BLOOD-CELLS - A POTENTIAL APPLICATION IN PERINATAL DIAGNOSIS

    JOURNAL OF IMMUNOLOGICAL METHODS, 1993

    Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple gl

    Human antibodies and hybridomas, 1992

    HUMAN MONOCLONAL-ANTIBODY RECOGNIZING AN ANTIGEN ASSOCIATED WITH OVARIAN AND OTHER ADENOCARCINOMAS

    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992

    THE ONTOGENY AND FUNCTIONAL-CHARACTERISTICS OF HUMAN B-1 (CD5+B) CELLS

    INTERNATIONAL IMMUNOLOGY, 1992

    CRITICAL REASSESSMENT OF 2ND LOOK EXPLORATORY LAPAROTOMY FOR EPITHELIAL OVARIAN-CARCINOMA

    CANCER, 1992

    MODIFIED POSTERIOR EXENTERATION FOR OVARIAN-CANCER

    OBSTETRICS AND GYNECOLOGY, 1991

    OPTICAL BIOSENSOR ASSAY (OBA)

    Tsay, Y. G., Lin, C. I., Lee, J., Gustafson, E. K., APPELQVIST, R., MA, 1991

    QUANTITATIVE PROTEIN-CHANGES IN METASTATIC VERSUS PRIMARY EPITHELIAL OVARIAN-CARCINOMA

    GYNECOLOGIC ONCOLOGY, 1991

    TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK WITH HA

    NEW ENGLAND JOURNAL OF MEDICINE, 1991

    Gynecologic factors in sexual dysfunction of the older woman.

    Clinics in geriatric medicine, 1991

    WOMEN WITH PREECLAMPSIA HAVE HIGHER PLASMA ENDOTHELIN LEVELS THAN WOMEN WITH NORMAL PREGNANCIES

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990

    Synthesis and Characterization of Gentiobiose Heptaacetate Conjugate Vaccines That Produce

    BIOCONJUGATE CHEMISTRY, 1990

    STUDY OF THE SELECTIVE CYTOTOXIC PROPERTIES OF CATIONIC

    GYNECOLOGIC ONCOLOGY, 1990

    ONE-STEP SEPARATION OF HUMAN FETAL LYMPHOCYTES FROM NUCLEATED RED-BLOOD-CELLS

    JOURNAL OF IMMUNOLOGICAL METHODS, 1990

    DELIVERY OF A NORMAL INFANT FOLLOWING CISPLATIN, VINBLASTINE

    GYNECOLOGIC ONCOLOGY, 1990

    INITIAL EVALUATION OF A HUMAN IMMUNOGLOBULIN-M MONOCLONAL-ANTIBODY (HA-1A) IN HUMANS

    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990

    PROSPECTIVE RANDOMIZED TRIAL OF TOPICAL ALPHA-INTERFERON

    GYNECOLOGIC ONCOLOGY, 1990

    A RANDOMIZED COMPARATIVE TRIAL OF CARBOPLATIN AND IPROPLATIN IN ADVANCED SQUAMOUS CARCINOMA

    JOURNAL OF CLINICAL ONCOLOGY, 1989

    RADIATION-THERAPY FOR PRIMARY SQUAMOUS

    GYNECOLOGIC ONCOLOGY, 1989

    DELETION OF HISTO-BLOOD GROUP

    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989

    EFFECTS OF ANTI-LIPID A HUMAN MONOCLONAL

    JOURNAL OF UROLOGY, 1989

    TOPICAL INTERFERON FOR TREATING CONDYLOMA ACUMINATA IN WOMEN

    JOURNAL OF INFECTIOUS DISEASES, 1988

    GENERATION OF HUMAN MONOCLONAL-ANTIBODIES TO CANCER

    JOURNAL OF IMMUNOLOGICAL METHODS, 1987

    CARDIOVASCULAR EFFECT OF INTRAVENOUS LIPID-A IN RABBITS

    CIRCULATORY SHOCK, 1987

    SINGLE-DOSE ACTINOMYCIN

    CANCER, 1987

    CLINICAL-APPLICATIONS OF MONOCLONAL-ANTIBODIES IN GYNECOLOGIC ONCOLOGY

    CANCER, 1987

    THE EFFECT OF HUMAN ANTIENDOTOXIN MONOCLONAL-ANTIBODIES ON ENDOTOXIN-INDUCED LUNG INJURY IN THE RAT

    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987

    EPITHELIAL OVARIAN-CARCINOMA IN PATIENTS WITH INTERSEX DISORDERS

    GYNECOLOGIC ONCOLOGY, 1986

    INFLUENCE OF AVIDITY AND IDIOTOPE RECOGNITION ON THE MODULATION OF SURFACE

    JOURNAL OF IMMUNOLOGY, 1986

    A CRITICAL REASSESSMENT OF 2ND-LOOK LAPAROTOMY IN EPITHELIAL OVARIAN-CARCINOMA

    CANCER, 1986

    PROTECTION AGAINST GRAM-NEGATIVE BACTEREMIA AND ENDOTOXEMIA WITH HUMAN MONOCLONAL IGM ANTIBODIES

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1985

    ANTIBODIES TO PEPTIDES CORRESPONDING TO A CONSERVED SEQUENCE OF GONOCOCCAL PILINS BLOCK BACTERIAL

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1985

    PRODUCTION OF HUMAN MONOCLONAL IGG ANTIBODIES AGAINST RHESUS (D) ANTIGEN

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1984

    PARTIAL HYDATIDIFORM MOLE WITH DIPLOID KARYOTYPE - REPORT OF 3 CASES

    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984

    SOMATIC-CELL HYBRID SELECTION WITH A TRANSFECTABLE DOMINANT MARKER

    SOMATIC CELL AND MOLECULAR GENETICS, 1984

    2ND-LOOK LAPAROTOMY IN EPITHELIAL OVARIAN-CARCINOMA - PRECISE DEFINITION, SENSITIVITY

    GYNECOLOGIC ONCOLOGY, 1984

    MONOCLONAL VERSUS POLYCLONAL ANTIBODY-RADIOIMMUNOASSAY AGAINST THE BETA

    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983

    CONSTRUCTION AND TESTING OF MOUSE HUMAN HETEROMYELOMAS FOR HUMAN MONOCLONAL-ANTIBODY PRODUCTION

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1983

    CHARACTERIZATION OF AN ALPHA-BUNGAROTOXIN BINDING COMPONENT FROM DROSOPHILA - MELANOGASTER

    JOURNAL OF NEUROCHEMISTRY, 1977

    APPEARANCE OF ACETYLCHOLINE RECEPTORS IN CULTURED MYOBLASTS PRIOR TO FUSION

    JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1976

    MITOGENICITY OF THROMBIN AND SURFACE ALTERATIONS ON MOUSE SPLENOCYTES

    EXPERIMENTAL CELL RESEARCH

    What is Dr. Teng's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Teng's National Provider Identifier (NPI) number is 1245379510.

    What common questions do patients ask about Dr. Teng?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Teng

    What is Dr. Nelson Teng's specialty?

    Dr. Teng is a Obstetrician / Gynecologist (OBGYN) near Stanford, CA. An obstetrician/gynecologist has specialized knowledge, skills, and expertise in the medical and surgical management of the female reproductive system and related disorders. This physician acts as a consultant to other healthcare providers while also serving as a primary care physician for women, addressing their unique health needs throughout various stages of life. Contact Dr. Teng to book an appointment today.

    Is this Dr. Nelson Teng affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Teng is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Obstetrician / Gynecologist (OBGYN)?

    Explore Obstetrician / Gynecologist (OBGYN) with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Nelson Teng accepting new patients in Stanford, CA?

    Yes, Dr. Nelson Teng is accepting new patients at this time.

    Does Dr. Nelson Teng offer online booking?

    Please contact Dr. Teng's office at (650) 498-8080 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Nelson Teng?

    Please contact Dr. Teng's office at (650) 498-8080 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Nelson Teng have?

    Dr. Nelson Teng is certified by the American Board of Obstetrics and Gynecology.

    Other Obstetrician / Gynecologist (OBGYN) Near Stanford, CA

    FD

    Obstetrician / Gynecologist (OBGYN)

    acceptingPatients-iconAccepting patients
    Stanford, CA
    AH

    Complex Family Planning Specialist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    acceptingPatients-iconAccepting patients
    Stanford, CA
    See All Specialists

    Doctors by Category

    Specialists